Serodiagnosis of chronic and acute Chagas´disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries

2018-04-242018-04-242004-01UMEZAWA, Eufrosina S.; LUQUETTI, Alejandro O.; LEVITUS, Gabriela; PONCE, Carlos; PONCE, Elisa; HENRIQUEZ, Diana; REVOLLO, Susana; ESPINOZA, Bertha; SOUSA, Octavio; KHAN, Baldip; SILVEIRA, José Franco da. Serodiagnosis of chronic and acute Chagas´disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries. Journal of Clinical Microbiology, Washington, v. 42, n. 1, p. 449-452, Jan. 2004.0095-1137e- 1098-660Xhttp://repositorio.bc.ufg.br/handle/ri/14597An enzyme-linked immunosorbent assay to diagnose Chagas’ disease by a serological test was performed with Trypanosoma cruzi recombinant antigens (JL8, MAP, and TcPo). High sensitivity (99.4%) and specificity (99.3%) were obtained when JL8 was combined with MAP (JM) and tested with 150 serum samples from chagasic and 142 nonchagasic individuals. Moreover, JM also diagnosed 84.2% of patients in the acute phase of T. cruzi infectionengAcesso AbertoCollaborative studyTrypanosoma cruziChagas diseaseSerodiagnosisSerodiagnosis of chronic and acute Chagas´disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countriesArtigo10.1128/JCM.42.1.449–452.2004